nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—PTGS2—asthma	0.254	1	CbGaD
Lenalidomide—ABCB1—Fluticasone furoate—asthma	0.0505	0.168	CbGbCtD
Lenalidomide—PTGS2—Triamcinolone—asthma	0.0462	0.154	CbGbCtD
Lenalidomide—ABCB1—Indacaterol—asthma	0.0412	0.137	CbGbCtD
Lenalidomide—PTGS2—Betamethasone—asthma	0.0396	0.132	CbGbCtD
Lenalidomide—PTGS2—Dexamethasone—asthma	0.0231	0.0767	CbGbCtD
Lenalidomide—ABCB1—Loratadine—asthma	0.022	0.0731	CbGbCtD
Lenalidomide—ABCB1—Methylprednisolone—asthma	0.0201	0.0669	CbGbCtD
Lenalidomide—ABCB1—Betamethasone—asthma	0.0131	0.0435	CbGbCtD
Lenalidomide—ABCB1—Prednisolone—asthma	0.0129	0.0429	CbGbCtD
Lenalidomide—ABCB1—Hydrocortisone—asthma	0.0122	0.0407	CbGbCtD
Lenalidomide—ABCB1—Prednisone—asthma	0.0122	0.0405	CbGbCtD
Lenalidomide—ABCB1—Dexamethasone—asthma	0.00761	0.0253	CbGbCtD
Lenalidomide—TNFSF11—respiratory system—asthma	0.00656	0.0921	CbGeAlD
Lenalidomide—CDH5—respiratory system—asthma	0.00494	0.0693	CbGeAlD
Lenalidomide—CDH5—adrenal cortex—asthma	0.00414	0.0581	CbGeAlD
Lenalidomide—CDH5—epithelium—asthma	0.00412	0.0579	CbGeAlD
Lenalidomide—CDH5—bronchus—asthma	0.00406	0.057	CbGeAlD
Lenalidomide—TNFSF11—adrenal gland—asthma	0.00397	0.0558	CbGeAlD
Lenalidomide—CDH5—smooth muscle tissue—asthma	0.00397	0.0558	CbGeAlD
Lenalidomide—CDH5—cardiovascular system—asthma	0.00378	0.053	CbGeAlD
Lenalidomide—CDH5—trachea—asthma	0.00365	0.0512	CbGeAlD
Lenalidomide—TNFSF11—lung—asthma	0.00348	0.0489	CbGeAlD
Lenalidomide—CRBN—respiratory system—asthma	0.00314	0.044	CbGeAlD
Lenalidomide—CDH5—adrenal gland—asthma	0.00299	0.042	CbGeAlD
Lenalidomide—CRBN—adrenal cortex—asthma	0.00263	0.0369	CbGeAlD
Lenalidomide—CDH5—lung—asthma	0.00262	0.0368	CbGeAlD
Lenalidomide—CRBN—bronchus—asthma	0.00258	0.0362	CbGeAlD
Lenalidomide—CRBN—trachea—asthma	0.00232	0.0325	CbGeAlD
Lenalidomide—CRBN—adrenal gland—asthma	0.0019	0.0267	CbGeAlD
Lenalidomide—Pomalidomide—TNF—asthma	0.00177	0.412	CrCbGaD
Lenalidomide—CRBN—lung—asthma	0.00166	0.0234	CbGeAlD
Lenalidomide—Thalidomide—TNF—asthma	0.00114	0.266	CrCbGaD
Lenalidomide—PTGS2—respiratory system—asthma	0.000854	0.012	CbGeAlD
Lenalidomide—Pomalidomide—PTGS2—asthma	0.00084	0.196	CrCbGaD
Lenalidomide—PTGS2—adrenal cortex—asthma	0.000716	0.0101	CbGeAlD
Lenalidomide—PTGS2—epithelium—asthma	0.000713	0.01	CbGeAlD
Lenalidomide—PTGS2—bronchus—asthma	0.000703	0.00986	CbGeAlD
Lenalidomide—PTGS2—smooth muscle tissue—asthma	0.000687	0.00965	CbGeAlD
Lenalidomide—PTGS2—cardiovascular system—asthma	0.000654	0.00918	CbGeAlD
Lenalidomide—PTGS2—trachea—asthma	0.000631	0.00885	CbGeAlD
Lenalidomide—Thalidomide—PTGS2—asthma	0.000541	0.126	CrCbGaD
Lenalidomide—ABCB1—respiratory system—asthma	0.000528	0.00741	CbGeAlD
Lenalidomide—PTGS2—adrenal gland—asthma	0.000517	0.00726	CbGeAlD
Lenalidomide—PTGS2—Fluocinonide—Ciclesonide—asthma	0.000501	0.111	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Fluticasone furoate—asthma	0.000491	0.109	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Fluticasone Propionate—asthma	0.000458	0.101	CbGdCrCtD
Lenalidomide—PTGS2—lung—asthma	0.000453	0.00636	CbGeAlD
Lenalidomide—ABCB1—adrenal cortex—asthma	0.000443	0.00622	CbGeAlD
Lenalidomide—ABCB1—epithelium—asthma	0.000441	0.00619	CbGeAlD
Lenalidomide—ABCB1—cardiovascular system—asthma	0.000404	0.00568	CbGeAlD
Lenalidomide—ABCB1—trachea—asthma	0.00039	0.00548	CbGeAlD
Lenalidomide—PTGS2—Fluocinonide—Beclomethasone—asthma	0.000336	0.0745	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Budesonide—asthma	0.000323	0.0714	CbGdCrCtD
Lenalidomide—ABCB1—adrenal gland—asthma	0.00032	0.00449	CbGeAlD
Lenalidomide—PTGS2—Fluocinonide—Flunisolide—asthma	0.000318	0.0705	CbGdCrCtD
Lenalidomide—PTGS2—Fluticasone Propionate—Fluticasone furoate—asthma	0.000296	0.0656	CbGdCrCtD
Lenalidomide—ABCB1—lung—asthma	0.00028	0.00393	CbGeAlD
Lenalidomide—PTGS2—Fluocinonide—Mometasone—asthma	0.000261	0.0577	CbGdCrCtD
Lenalidomide—PTGS2—Fluticasone Propionate—Beclomethasone—asthma	0.000203	0.0449	CbGdCrCtD
Lenalidomide—PTGS2—Fluticasone Propionate—Flunisolide—asthma	0.000192	0.0425	CbGdCrCtD
Lenalidomide—PTGS2—Fluticasone Propionate—Mometasone—asthma	0.000157	0.0348	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Methylprednisolone—asthma	0.000156	0.0345	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Betamethasone—asthma	0.000153	0.0339	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Dexamethasone—asthma	0.000153	0.0339	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Triamcinolone—asthma	0.00015	0.0332	CbGdCrCtD
Lenalidomide—CDH5—Signaling Pathways—CMA1—asthma	0.000129	0.00155	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—VIP—asthma	0.000129	0.00155	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL13—asthma	0.000126	0.00152	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCR4—asthma	0.000123	0.00148	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—STAT6—asthma	0.000121	0.00146	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL2RB—asthma	0.000119	0.00143	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PDE4D—asthma	0.000118	0.00142	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—IL1R1—asthma	0.000117	0.00141	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL17A—asthma	0.000116	0.0014	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PDE4B—asthma	0.000115	0.00138	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—C5—asthma	0.000115	0.00138	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TACR1—asthma	0.000115	0.00138	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—CAT—asthma	0.000108	0.00131	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL12B—asthma	0.000108	0.0013	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL5—asthma	0.000108	0.0013	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-DPB1—asthma	0.000107	0.00129	CbGpPWpGaD
Lenalidomide—PTGS2—Overview of nanoparticle effects—IL6—asthma	0.000107	0.00129	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—GSTM1—asthma	0.000106	0.00128	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCR3—asthma	0.000105	0.00126	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—NOS1—asthma	0.000104	0.00125	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CD40—asthma	0.000103	0.00124	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NPY—asthma	0.000102	0.00123	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CTLA4—asthma	0.000102	0.00123	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—AGTR2—asthma	9.85e-05	0.00119	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—HMOX1—asthma	9.8e-05	0.00118	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—asthma	9.46e-05	0.00114	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CXCL10—asthma	9.44e-05	0.00114	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—AGTR1—asthma	9.44e-05	0.00114	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—EDNRB—asthma	9.43e-05	0.00114	CbGpPWpGaD
Lenalidomide—PTGS2—Fluticasone Propionate—Methylprednisolone—asthma	9.4e-05	0.0208	CbGdCrCtD
Lenalidomide—CDH5—Signaling Pathways—TAC1—asthma	9.34e-05	0.00112	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NPS—asthma	9.34e-05	0.00112	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—RAD50—asthma	9.3e-05	0.00112	CbGpPWpGaD
Lenalidomide—PTGS2—Fluticasone Propionate—Dexamethasone—asthma	9.25e-05	0.0205	CbGdCrCtD
Lenalidomide—PTGS2—Fluticasone Propionate—Betamethasone—asthma	9.25e-05	0.0205	CbGdCrCtD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—EDN1—asthma	9.24e-05	0.00111	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCR3—asthma	9.16e-05	0.0011	CbGpPWpGaD
Lenalidomide—PTGS2—Fluticasone Propionate—Triamcinolone—asthma	9.04e-05	0.02	CbGdCrCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—LTC4S—asthma	8.96e-05	0.00108	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-DQA1—asthma	8.96e-05	0.00108	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CYBA—asthma	8.87e-05	0.00107	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—asthma	8.8e-05	0.00106	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—SMAD3—asthma	8.79e-05	0.00106	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PARP1—asthma	8.68e-05	0.00105	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL5—asthma	8.68e-05	0.00105	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—CRP—asthma	8.61e-05	0.00104	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—BDNF—asthma	8.48e-05	0.00102	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—asthma	8.41e-05	0.00101	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-DQB1—asthma	8.38e-05	0.00101	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—BDKRB2—asthma	8.38e-05	0.00101	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IL1R1—asthma	8.29e-05	0.000998	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ADCY2—asthma	8.11e-05	0.000976	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL3—asthma	8.08e-05	0.000973	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CD86—asthma	8.07e-05	0.000972	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—ICAM1—asthma	7.91e-05	0.000953	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CD40LG—asthma	7.91e-05	0.000953	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL10—asthma	7.91e-05	0.000953	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL4—asthma	7.88e-05	0.000949	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—LTA4H—asthma	7.77e-05	0.000936	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL4—asthma	7.7e-05	0.000927	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—asthma	7.64e-05	0.00092	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—KNG1—asthma	7.62e-05	0.000918	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—AGTR1—asthma	7.58e-05	0.000912	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—TRPA1—asthma	7.56e-05	0.00091	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—LEP—asthma	7.52e-05	0.000905	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCL10—asthma	7.4e-05	0.000892	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NTRK1—asthma	7.26e-05	0.000875	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ADRB2—asthma	7.19e-05	0.000866	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—asthma	7.13e-05	0.000859	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—CCL2—asthma	7.08e-05	0.000853	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL2RA—asthma	7.05e-05	0.000849	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—asthma	7.01e-05	0.000844	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—NOS2—asthma	7e-05	0.000844	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—C3—asthma	6.99e-05	0.000842	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—EGFR—asthma	6.87e-05	0.000828	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ITPR1—asthma	6.8e-05	0.000819	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CDK2—asthma	6.76e-05	0.000814	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—LEP—asthma	6.66e-05	0.000802	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—SERPINE1—asthma	6.61e-05	0.000796	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—ALB—asthma	6.6e-05	0.000795	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—asthma	6.55e-05	0.000788	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TLR4—asthma	6.53e-05	0.000786	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CD86—asthma	6.47e-05	0.00078	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—EDN1—asthma	6.42e-05	0.000773	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCL5—asthma	6.37e-05	0.000768	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-DRB1—asthma	6.37e-05	0.000767	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PLA2G4A—asthma	6.35e-05	0.000765	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—BCL2—asthma	6.31e-05	0.000759	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	6.3e-05	0.000759	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CSF2—asthma	6.28e-05	0.000756	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—ICAM1—asthma	6.26e-05	0.000754	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—NOS2—asthma	6.21e-05	0.000748	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—asthma	6.12e-05	0.000738	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—SMAD3—asthma	6.11e-05	0.000736	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—CD4—asthma	6.03e-05	0.000727	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IFNG—asthma	6.02e-05	0.000725	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—asthma	5.9e-05	0.00071	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PPP2CA—asthma	5.85e-05	0.000704	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—asthma	5.77e-05	0.000695	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCR5—asthma	5.74e-05	0.000691	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL2RA—asthma	5.66e-05	0.000681	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—C3—asthma	5.61e-05	0.000676	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CCL2—asthma	5.6e-05	0.000674	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	5.51e-05	0.000663	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PDGFB—asthma	5.46e-05	0.000658	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL1B—asthma	5.37e-05	0.000647	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—LEP—asthma	5.22e-05	0.000629	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—asthma	5.06e-05	0.000609	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—RHOA—asthma	5.04e-05	0.000607	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—asthma	4.97e-05	0.000598	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—FN1—asthma	4.93e-05	0.000593	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—asthma	4.88e-05	0.000588	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	4.88e-05	0.000588	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IFNG—asthma	4.76e-05	0.000573	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CHAT—asthma	4.66e-05	0.000561	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IFNG—asthma	4.65e-05	0.00056	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—asthma	4.6e-05	0.000554	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—POMC—asthma	4.49e-05	0.00054	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	4.47e-05	0.000538	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CXCL8—asthma	4.43e-05	0.000533	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCL2—asthma	4.39e-05	0.000529	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL6R—asthma	4.38e-05	0.000527	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC26A4—asthma	4.34e-05	0.000523	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CXCL8—asthma	4.33e-05	0.000521	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL1B—asthma	4.25e-05	0.000511	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL2—asthma	4.23e-05	0.00051	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—asthma	4.15e-05	0.0005	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL1B—asthma	4.15e-05	0.0005	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL2—asthma	4.13e-05	0.000498	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—SERPINE1—asthma	4.1e-05	0.000494	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—asthma	4.09e-05	0.000493	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—asthma	4.06e-05	0.000489	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—MMP9—asthma	4e-05	0.000482	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LTC4S—asthma	3.99e-05	0.000481	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ATP4A—asthma	3.97e-05	0.000478	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC30A8—asthma	3.97e-05	0.000478	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CARM1—asthma	3.96e-05	0.000477	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—RHOA—asthma	3.95e-05	0.000476	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NOS3—asthma	3.91e-05	0.000471	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	3.9e-05	0.00047	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—TNF—asthma	3.9e-05	0.000469	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—VEGFA—asthma	3.51e-05	0.000423	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCL8—asthma	3.47e-05	0.000418	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LTA4H—asthma	3.46e-05	0.000417	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL2—asthma	3.32e-05	0.0004	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TGFB1—asthma	3.3e-05	0.000397	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—asthma	3.27e-05	0.000394	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—asthma	3.26e-05	0.000392	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—EGFR—asthma	3.24e-05	0.00039	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—TGFB1—asthma	3.22e-05	0.000388	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL6—asthma	3.14e-05	0.000379	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MMP9—asthma	3.14e-05	0.000378	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PTEN—asthma	3.12e-05	0.000376	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TNF—asthma	3.08e-05	0.000371	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ARG1—asthma	3.03e-05	0.000364	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—TNF—asthma	3.01e-05	0.000363	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LTC4S—asthma	2.83e-05	0.000341	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—VEGFA—asthma	2.82e-05	0.00034	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—STAT3—asthma	2.79e-05	0.000336	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALDH7A1—asthma	2.74e-05	0.00033	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—asthma	2.71e-05	0.000326	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—CARM1—asthma	2.67e-05	0.000321	CbGpPWpGaD
Lenalidomide—Discomfort—Hydrocortisone—asthma	2.66e-05	9.45e-05	CcSEcCtD
Lenalidomide—Connective tissue disorder—Prednisone—asthma	2.66e-05	9.44e-05	CcSEcCtD
Lenalidomide—Nausea—Budesonide—asthma	2.66e-05	9.42e-05	CcSEcCtD
Lenalidomide—Oedema—Prednisolone—asthma	2.65e-05	9.39e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—ARG2—asthma	2.62e-05	0.000316	CbGpPWpGaD
Lenalidomide—Loss of consciousness—Triamcinolone—asthma	2.62e-05	9.3e-05	CcSEcCtD
Lenalidomide—Loss of consciousness—Methylprednisolone—asthma	2.62e-05	9.28e-05	CcSEcCtD
Lenalidomide—Shock—Prednisolone—asthma	2.6e-05	9.24e-05	CcSEcCtD
Lenalidomide—Cough—Triamcinolone—asthma	2.6e-05	9.23e-05	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—TGFB1—asthma	2.59e-05	0.000312	CbGpPWpGaD
Lenalidomide—Oedema—Hydrocortisone—asthma	2.59e-05	9.17e-05	CcSEcCtD
Lenalidomide—Tachycardia—Prednisolone—asthma	2.58e-05	9.17e-05	CcSEcCtD
Lenalidomide—Hypertension—Triamcinolone—asthma	2.58e-05	9.14e-05	CcSEcCtD
Lenalidomide—Hypertension—Methylprednisolone—asthma	2.57e-05	9.12e-05	CcSEcCtD
Lenalidomide—Infection—Hydrocortisone—asthma	2.57e-05	9.11e-05	CcSEcCtD
Lenalidomide—Hyperhidrosis—Prednisolone—asthma	2.56e-05	9.08e-05	CcSEcCtD
Lenalidomide—Shock—Hydrocortisone—asthma	2.54e-05	9.02e-05	CcSEcCtD
Lenalidomide—Myalgia—Triamcinolone—asthma	2.54e-05	9.01e-05	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—EGFR—asthma	2.54e-05	0.000306	CbGpPWpGaD
Lenalidomide—Nervous system disorder—Hydrocortisone—asthma	2.54e-05	9e-05	CcSEcCtD
Lenalidomide—Arthralgia—Methylprednisolone—asthma	2.53e-05	8.99e-05	CcSEcCtD
Lenalidomide—Myalgia—Methylprednisolone—asthma	2.53e-05	8.99e-05	CcSEcCtD
Lenalidomide—Eye disorder—Prednisone—asthma	2.53e-05	8.98e-05	CcSEcCtD
Lenalidomide—Anxiety—Methylprednisolone—asthma	2.52e-05	8.96e-05	CcSEcCtD
Lenalidomide—Tachycardia—Hydrocortisone—asthma	2.52e-05	8.95e-05	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	2.52e-05	8.93e-05	CcSEcCtD
Lenalidomide—Flushing—Prednisone—asthma	2.51e-05	8.92e-05	CcSEcCtD
Lenalidomide—Skin disorder—Hydrocortisone—asthma	2.51e-05	8.91e-05	CcSEcCtD
Lenalidomide—Ill-defined disorder—Betamethasone—asthma	2.51e-05	8.91e-05	CcSEcCtD
Lenalidomide—Ill-defined disorder—Dexamethasone—asthma	2.51e-05	8.91e-05	CcSEcCtD
Lenalidomide—Discomfort—Triamcinolone—asthma	2.51e-05	8.9e-05	CcSEcCtD
Lenalidomide—Discomfort—Methylprednisolone—asthma	2.5e-05	8.88e-05	CcSEcCtD
Lenalidomide—Hyperhidrosis—Hydrocortisone—asthma	2.5e-05	8.87e-05	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—IL6—asthma	2.49e-05	0.000299	CbGpPWpGaD
Lenalidomide—Dry mouth—Triamcinolone—asthma	2.48e-05	8.81e-05	CcSEcCtD
Lenalidomide—Angioedema—Dexamethasone—asthma	2.47e-05	8.77e-05	CcSEcCtD
Lenalidomide—Angioedema—Betamethasone—asthma	2.47e-05	8.77e-05	CcSEcCtD
Lenalidomide—Anorexia—Hydrocortisone—asthma	2.46e-05	8.74e-05	CcSEcCtD
Lenalidomide—Angiopathy—Prednisone—asthma	2.46e-05	8.72e-05	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—LTA4H—asthma	2.45e-05	0.000296	CbGpPWpGaD
Lenalidomide—Confusional state—Methylprednisolone—asthma	2.45e-05	8.69e-05	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	2.45e-05	0.000295	CbGpPWpGaD
Lenalidomide—Immune system disorder—Prednisone—asthma	2.45e-05	8.68e-05	CcSEcCtD
Lenalidomide—Malaise—Betamethasone—asthma	2.44e-05	8.66e-05	CcSEcCtD
Lenalidomide—Malaise—Dexamethasone—asthma	2.44e-05	8.66e-05	CcSEcCtD
Lenalidomide—Oedema—Triamcinolone—asthma	2.43e-05	8.64e-05	CcSEcCtD
Lenalidomide—Vertigo—Dexamethasone—asthma	2.43e-05	8.63e-05	CcSEcCtD
Lenalidomide—Vertigo—Betamethasone—asthma	2.43e-05	8.63e-05	CcSEcCtD
Lenalidomide—Syncope—Dexamethasone—asthma	2.43e-05	8.61e-05	CcSEcCtD
Lenalidomide—Syncope—Betamethasone—asthma	2.43e-05	8.61e-05	CcSEcCtD
Lenalidomide—Arrhythmia—Prednisone—asthma	2.42e-05	8.58e-05	CcSEcCtD
Lenalidomide—Infection—Triamcinolone—asthma	2.42e-05	8.58e-05	CcSEcCtD
Lenalidomide—Hypotension—Hydrocortisone—asthma	2.42e-05	8.57e-05	CcSEcCtD
Lenalidomide—Infection—Methylprednisolone—asthma	2.41e-05	8.56e-05	CcSEcCtD
Lenalidomide—Shock—Triamcinolone—asthma	2.39e-05	8.5e-05	CcSEcCtD
Lenalidomide—Insomnia—Prednisolone—asthma	2.39e-05	8.49e-05	CcSEcCtD
Lenalidomide—Alopecia—Prednisone—asthma	2.39e-05	8.49e-05	CcSEcCtD
Lenalidomide—Shock—Methylprednisolone—asthma	2.39e-05	8.48e-05	CcSEcCtD
Lenalidomide—Nervous system disorder—Methylprednisolone—asthma	2.38e-05	8.45e-05	CcSEcCtD
Lenalidomide—Loss of consciousness—Dexamethasone—asthma	2.38e-05	8.44e-05	CcSEcCtD
Lenalidomide—Loss of consciousness—Betamethasone—asthma	2.38e-05	8.44e-05	CcSEcCtD
Lenalidomide—Paraesthesia—Prednisolone—asthma	2.38e-05	8.43e-05	CcSEcCtD
Lenalidomide—Tachycardia—Triamcinolone—asthma	2.38e-05	8.43e-05	CcSEcCtD
Lenalidomide—Mental disorder—Prednisone—asthma	2.37e-05	8.42e-05	CcSEcCtD
Lenalidomide—Tachycardia—Methylprednisolone—asthma	2.37e-05	8.41e-05	CcSEcCtD
Lenalidomide—Skin disorder—Methylprednisolone—asthma	2.36e-05	8.37e-05	CcSEcCtD
Lenalidomide—Erythema—Prednisone—asthma	2.36e-05	8.36e-05	CcSEcCtD
Lenalidomide—Malnutrition—Prednisone—asthma	2.36e-05	8.36e-05	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Hydrocortisone—asthma	2.36e-05	8.36e-05	CcSEcCtD
Lenalidomide—Hyperhidrosis—Triamcinolone—asthma	2.35e-05	8.35e-05	CcSEcCtD
Lenalidomide—Hyperhidrosis—Methylprednisolone—asthma	2.35e-05	8.33e-05	CcSEcCtD
Lenalidomide—Insomnia—Hydrocortisone—asthma	2.34e-05	8.3e-05	CcSEcCtD
Lenalidomide—Hypertension—Betamethasone—asthma	2.34e-05	8.29e-05	CcSEcCtD
Lenalidomide—Hypertension—Dexamethasone—asthma	2.34e-05	8.29e-05	CcSEcCtD
Lenalidomide—Paraesthesia—Hydrocortisone—asthma	2.32e-05	8.24e-05	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—asthma	2.32e-05	0.000279	CbGpPWpGaD
Lenalidomide—Myalgia—Betamethasone—asthma	2.3e-05	8.17e-05	CcSEcCtD
Lenalidomide—Myalgia—Dexamethasone—asthma	2.3e-05	8.17e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	2.3e-05	0.000277	CbGpPWpGaD
Lenalidomide—Anxiety—Dexamethasone—asthma	2.3e-05	8.15e-05	CcSEcCtD
Lenalidomide—Anxiety—Betamethasone—asthma	2.3e-05	8.15e-05	CcSEcCtD
Lenalidomide—Discomfort—Betamethasone—asthma	2.28e-05	8.08e-05	CcSEcCtD
Lenalidomide—Discomfort—Dexamethasone—asthma	2.28e-05	8.08e-05	CcSEcCtD
Lenalidomide—Dyspepsia—Hydrocortisone—asthma	2.28e-05	8.07e-05	CcSEcCtD
Lenalidomide—Hypotension—Methylprednisolone—asthma	2.27e-05	8.05e-05	CcSEcCtD
Lenalidomide—Pain—Prednisolone—asthma	2.26e-05	8.03e-05	CcSEcCtD
Lenalidomide—Decreased appetite—Hydrocortisone—asthma	2.25e-05	7.97e-05	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	2.24e-05	0.00027	CbGpPWpGaD
Lenalidomide—Gastrointestinal disorder—Hydrocortisone—asthma	2.23e-05	7.92e-05	CcSEcCtD
Lenalidomide—Fatigue—Hydrocortisone—asthma	2.23e-05	7.91e-05	CcSEcCtD
Lenalidomide—Vision blurred—Prednisone—asthma	2.22e-05	7.88e-05	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Triamcinolone—asthma	2.22e-05	7.87e-05	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Methylprednisolone—asthma	2.21e-05	7.85e-05	CcSEcCtD
Lenalidomide—Pain—Hydrocortisone—asthma	2.21e-05	7.84e-05	CcSEcCtD
Lenalidomide—Oedema—Dexamethasone—asthma	2.21e-05	7.84e-05	CcSEcCtD
Lenalidomide—Oedema—Betamethasone—asthma	2.21e-05	7.84e-05	CcSEcCtD
Lenalidomide—Insomnia—Triamcinolone—asthma	2.2e-05	7.81e-05	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—asthma	2.2e-05	0.000265	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	2.2e-05	0.000265	CbGpPWpGaD
Lenalidomide—Insomnia—Methylprednisolone—asthma	2.2e-05	7.79e-05	CcSEcCtD
Lenalidomide—Infection—Dexamethasone—asthma	2.19e-05	7.79e-05	CcSEcCtD
Lenalidomide—Infection—Betamethasone—asthma	2.19e-05	7.79e-05	CcSEcCtD
Lenalidomide—Ill-defined disorder—Prednisone—asthma	2.19e-05	7.76e-05	CcSEcCtD
Lenalidomide—Paraesthesia—Triamcinolone—asthma	2.19e-05	7.76e-05	CcSEcCtD
Lenalidomide—Feeling abnormal—Prednisolone—asthma	2.18e-05	7.74e-05	CcSEcCtD
Lenalidomide—Paraesthesia—Methylprednisolone—asthma	2.18e-05	7.74e-05	CcSEcCtD
Lenalidomide—Anaemia—Prednisone—asthma	2.18e-05	7.73e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—ALOX15—asthma	2.17e-05	0.000262	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALOX5AP—asthma	2.17e-05	0.000262	CbGpPWpGaD
Lenalidomide—Shock—Dexamethasone—asthma	2.17e-05	7.71e-05	CcSEcCtD
Lenalidomide—Shock—Betamethasone—asthma	2.17e-05	7.71e-05	CcSEcCtD
Lenalidomide—Dyspnoea—Triamcinolone—asthma	2.17e-05	7.7e-05	CcSEcCtD
Lenalidomide—Nervous system disorder—Betamethasone—asthma	2.17e-05	7.69e-05	CcSEcCtD
Lenalidomide—Nervous system disorder—Dexamethasone—asthma	2.17e-05	7.69e-05	CcSEcCtD
Lenalidomide—Agitation—Prednisone—asthma	2.17e-05	7.68e-05	CcSEcCtD
Lenalidomide—Thrombocytopenia—Dexamethasone—asthma	2.16e-05	7.67e-05	CcSEcCtD
Lenalidomide—Thrombocytopenia—Betamethasone—asthma	2.16e-05	7.67e-05	CcSEcCtD
Lenalidomide—Tachycardia—Betamethasone—asthma	2.16e-05	7.65e-05	CcSEcCtD
Lenalidomide—Tachycardia—Dexamethasone—asthma	2.16e-05	7.65e-05	CcSEcCtD
Lenalidomide—Angioedema—Prednisone—asthma	2.15e-05	7.64e-05	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—ARG1—asthma	2.14e-05	0.000258	CbGpPWpGaD
Lenalidomide—Dyspepsia—Triamcinolone—asthma	2.14e-05	7.6e-05	CcSEcCtD
Lenalidomide—Dyspepsia—Methylprednisolone—asthma	2.14e-05	7.59e-05	CcSEcCtD
Lenalidomide—Hyperhidrosis—Dexamethasone—asthma	2.14e-05	7.58e-05	CcSEcCtD
Lenalidomide—Hyperhidrosis—Betamethasone—asthma	2.14e-05	7.58e-05	CcSEcCtD
Lenalidomide—Feeling abnormal—Hydrocortisone—asthma	2.13e-05	7.56e-05	CcSEcCtD
Lenalidomide—Malaise—Prednisone—asthma	2.13e-05	7.54e-05	CcSEcCtD
Lenalidomide—Vertigo—Prednisone—asthma	2.12e-05	7.51e-05	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Hydrocortisone—asthma	2.11e-05	7.5e-05	CcSEcCtD
Lenalidomide—Syncope—Prednisone—asthma	2.11e-05	7.5e-05	CcSEcCtD
Lenalidomide—Anorexia—Dexamethasone—asthma	2.11e-05	7.47e-05	CcSEcCtD
Lenalidomide—Anorexia—Betamethasone—asthma	2.11e-05	7.47e-05	CcSEcCtD
Lenalidomide—Urticaria—Prednisolone—asthma	2.1e-05	7.46e-05	CcSEcCtD
Lenalidomide—Fatigue—Triamcinolone—asthma	2.1e-05	7.45e-05	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—asthma	2.1e-05	0.000252	CbGpPWpGaD
Lenalidomide—Fatigue—Methylprednisolone—asthma	2.09e-05	7.43e-05	CcSEcCtD
Lenalidomide—Pain—Triamcinolone—asthma	2.08e-05	7.39e-05	CcSEcCtD
Lenalidomide—PTGS2—Disease—DCN—asthma	2.08e-05	0.00025	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CHAT—asthma	2.07e-05	0.00025	CbGpPWpGaD
Lenalidomide—Loss of consciousness—Prednisone—asthma	2.07e-05	7.35e-05	CcSEcCtD
Lenalidomide—Hypotension—Dexamethasone—asthma	2.06e-05	7.32e-05	CcSEcCtD
Lenalidomide—Hypotension—Betamethasone—asthma	2.06e-05	7.32e-05	CcSEcCtD
Lenalidomide—Urticaria—Hydrocortisone—asthma	2.05e-05	7.29e-05	CcSEcCtD
Lenalidomide—Abdominal pain—Hydrocortisone—asthma	2.04e-05	7.25e-05	CcSEcCtD
Lenalidomide—Body temperature increased—Hydrocortisone—asthma	2.04e-05	7.25e-05	CcSEcCtD
Lenalidomide—Hypertension—Prednisone—asthma	2.03e-05	7.22e-05	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Dexamethasone—asthma	2.01e-05	7.14e-05	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Betamethasone—asthma	2.01e-05	7.14e-05	CcSEcCtD
Lenalidomide—Arthralgia—Prednisone—asthma	2.01e-05	7.12e-05	CcSEcCtD
Lenalidomide—Myalgia—Prednisone—asthma	2.01e-05	7.12e-05	CcSEcCtD
Lenalidomide—Feeling abnormal—Triamcinolone—asthma	2.01e-05	7.12e-05	CcSEcCtD
Lenalidomide—Feeling abnormal—Methylprednisolone—asthma	2e-05	7.1e-05	CcSEcCtD
Lenalidomide—Anxiety—Prednisone—asthma	2e-05	7.09e-05	CcSEcCtD
Lenalidomide—Insomnia—Dexamethasone—asthma	2e-05	7.09e-05	CcSEcCtD
Lenalidomide—Insomnia—Betamethasone—asthma	2e-05	7.09e-05	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	1.99e-05	7.07e-05	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Methylprednisolone—asthma	1.99e-05	7.05e-05	CcSEcCtD
Lenalidomide—Paraesthesia—Dexamethasone—asthma	1.98e-05	7.04e-05	CcSEcCtD
Lenalidomide—Paraesthesia—Betamethasone—asthma	1.98e-05	7.04e-05	CcSEcCtD
Lenalidomide—Discomfort—Prednisone—asthma	1.98e-05	7.03e-05	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ADCY2—asthma	1.98e-05	0.000238	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Prednisolone—asthma	1.95e-05	6.92e-05	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—IL6—asthma	1.95e-05	0.000235	CbGpPWpGaD
Lenalidomide—Dyspepsia—Dexamethasone—asthma	1.94e-05	6.9e-05	CcSEcCtD
Lenalidomide—Dyspepsia—Betamethasone—asthma	1.94e-05	6.9e-05	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—ALDH7A1—asthma	1.94e-05	0.000234	CbGpPWpGaD
Lenalidomide—Urticaria—Triamcinolone—asthma	1.93e-05	6.86e-05	CcSEcCtD
Lenalidomide—Urticaria—Methylprednisolone—asthma	1.93e-05	6.85e-05	CcSEcCtD
Lenalidomide—Body temperature increased—Triamcinolone—asthma	1.92e-05	6.83e-05	CcSEcCtD
Lenalidomide—Oedema—Prednisone—asthma	1.92e-05	6.82e-05	CcSEcCtD
Lenalidomide—Abdominal pain—Methylprednisolone—asthma	1.92e-05	6.81e-05	CcSEcCtD
Lenalidomide—Decreased appetite—Betamethasone—asthma	1.92e-05	6.81e-05	CcSEcCtD
Lenalidomide—Decreased appetite—Dexamethasone—asthma	1.92e-05	6.81e-05	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—asthma	1.92e-05	0.000231	CbGpPWpGaD
Lenalidomide—Infection—Prednisone—asthma	1.91e-05	6.78e-05	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Betamethasone—asthma	1.91e-05	6.77e-05	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Dexamethasone—asthma	1.91e-05	6.77e-05	CcSEcCtD
Lenalidomide—Hypersensitivity—Hydrocortisone—asthma	1.9e-05	6.76e-05	CcSEcCtD
Lenalidomide—Fatigue—Dexamethasone—asthma	1.9e-05	6.76e-05	CcSEcCtD
Lenalidomide—Fatigue—Betamethasone—asthma	1.9e-05	6.76e-05	CcSEcCtD
Lenalidomide—Shock—Prednisone—asthma	1.89e-05	6.71e-05	CcSEcCtD
Lenalidomide—Pain—Betamethasone—asthma	1.89e-05	6.7e-05	CcSEcCtD
Lenalidomide—Pain—Dexamethasone—asthma	1.89e-05	6.7e-05	CcSEcCtD
Lenalidomide—Nervous system disorder—Prednisone—asthma	1.89e-05	6.69e-05	CcSEcCtD
Lenalidomide—Tachycardia—Prednisone—asthma	1.88e-05	6.66e-05	CcSEcCtD
Lenalidomide—Skin disorder—Prednisone—asthma	1.87e-05	6.63e-05	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—ARG2—asthma	1.86e-05	0.000224	CbGpPWpGaD
Lenalidomide—Hyperhidrosis—Prednisone—asthma	1.86e-05	6.6e-05	CcSEcCtD
Lenalidomide—Asthenia—Hydrocortisone—asthma	1.85e-05	6.58e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—ALOX5—asthma	1.85e-05	0.000223	CbGpPWpGaD
Lenalidomide—Anorexia—Prednisone—asthma	1.83e-05	6.51e-05	CcSEcCtD
Lenalidomide—Pruritus—Hydrocortisone—asthma	1.83e-05	6.49e-05	CcSEcCtD
Lenalidomide—Feeling abnormal—Betamethasone—asthma	1.82e-05	6.46e-05	CcSEcCtD
Lenalidomide—Feeling abnormal—Dexamethasone—asthma	1.82e-05	6.46e-05	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Betamethasone—asthma	1.81e-05	6.41e-05	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Dexamethasone—asthma	1.81e-05	6.41e-05	CcSEcCtD
Lenalidomide—Hypersensitivity—Triamcinolone—asthma	1.79e-05	6.36e-05	CcSEcCtD
Lenalidomide—Hypersensitivity—Methylprednisolone—asthma	1.79e-05	6.35e-05	CcSEcCtD
Lenalidomide—Diarrhoea—Hydrocortisone—asthma	1.77e-05	6.28e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—CARM1—asthma	1.76e-05	0.000212	CbGpPWpGaD
Lenalidomide—Urticaria—Dexamethasone—asthma	1.75e-05	6.23e-05	CcSEcCtD
Lenalidomide—Urticaria—Betamethasone—asthma	1.75e-05	6.23e-05	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Prednisone—asthma	1.75e-05	6.22e-05	CcSEcCtD
Lenalidomide—Dizziness—Prednisolone—asthma	1.75e-05	6.21e-05	CcSEcCtD
Lenalidomide—Asthenia—Triamcinolone—asthma	1.75e-05	6.2e-05	CcSEcCtD
Lenalidomide—Abdominal pain—Betamethasone—asthma	1.75e-05	6.2e-05	CcSEcCtD
Lenalidomide—Body temperature increased—Dexamethasone—asthma	1.75e-05	6.2e-05	CcSEcCtD
Lenalidomide—Body temperature increased—Betamethasone—asthma	1.75e-05	6.2e-05	CcSEcCtD
Lenalidomide—Abdominal pain—Dexamethasone—asthma	1.75e-05	6.2e-05	CcSEcCtD
Lenalidomide—Asthenia—Methylprednisolone—asthma	1.74e-05	6.18e-05	CcSEcCtD
Lenalidomide—Insomnia—Prednisone—asthma	1.74e-05	6.17e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—DCN—asthma	1.74e-05	0.000209	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	1.73e-05	0.000209	CbGpPWpGaD
Lenalidomide—Paraesthesia—Prednisone—asthma	1.73e-05	6.13e-05	CcSEcCtD
Lenalidomide—Pruritus—Triamcinolone—asthma	1.72e-05	6.11e-05	CcSEcCtD
Lenalidomide—Pruritus—Methylprednisolone—asthma	1.72e-05	6.1e-05	CcSEcCtD
Lenalidomide—Dizziness—Hydrocortisone—asthma	1.71e-05	6.07e-05	CcSEcCtD
Lenalidomide—PTGS2—Disease—CYBA—asthma	1.71e-05	0.000206	CbGpPWpGaD
Lenalidomide—Dyspepsia—Prednisone—asthma	1.69e-05	6.01e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—ALDH2—asthma	1.69e-05	0.000204	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PARP1—asthma	1.67e-05	0.000201	CbGpPWpGaD
Lenalidomide—Decreased appetite—Prednisone—asthma	1.67e-05	5.93e-05	CcSEcCtD
Lenalidomide—Rash—Prednisolone—asthma	1.67e-05	5.92e-05	CcSEcCtD
Lenalidomide—Dermatitis—Prednisolone—asthma	1.67e-05	5.92e-05	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—HMOX1—asthma	1.66e-05	0.0002	CbGpPWpGaD
Lenalidomide—Diarrhoea—Methylprednisolone—asthma	1.66e-05	5.9e-05	CcSEcCtD
Lenalidomide—Fatigue—Prednisone—asthma	1.66e-05	5.88e-05	CcSEcCtD
Lenalidomide—Headache—Prednisolone—asthma	1.66e-05	5.88e-05	CcSEcCtD
Lenalidomide—Constipation—Prednisone—asthma	1.64e-05	5.84e-05	CcSEcCtD
Lenalidomide—Vomiting—Hydrocortisone—asthma	1.64e-05	5.83e-05	CcSEcCtD
Lenalidomide—Rash—Hydrocortisone—asthma	1.63e-05	5.78e-05	CcSEcCtD
Lenalidomide—Dermatitis—Hydrocortisone—asthma	1.63e-05	5.78e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—asthma	1.63e-05	0.000196	CbGpPWpGaD
Lenalidomide—Headache—Hydrocortisone—asthma	1.62e-05	5.75e-05	CcSEcCtD
Lenalidomide—Dizziness—Triamcinolone—asthma	1.61e-05	5.71e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—GSTT1—asthma	1.61e-05	0.000194	CbGpPWpGaD
Lenalidomide—Dizziness—Methylprednisolone—asthma	1.61e-05	5.7e-05	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	1.59e-05	0.000192	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Prednisone—asthma	1.59e-05	5.62e-05	CcSEcCtD
Lenalidomide—Asthenia—Betamethasone—asthma	1.58e-05	5.62e-05	CcSEcCtD
Lenalidomide—Asthenia—Dexamethasone—asthma	1.58e-05	5.62e-05	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Prednisone—asthma	1.57e-05	5.58e-05	CcSEcCtD
Lenalidomide—PTGS2—Disease—NOS1—asthma	1.57e-05	0.000189	CbGpPWpGaD
Lenalidomide—Nausea—Prednisolone—asthma	1.57e-05	5.58e-05	CcSEcCtD
Lenalidomide—Pruritus—Betamethasone—asthma	1.56e-05	5.54e-05	CcSEcCtD
Lenalidomide—Pruritus—Dexamethasone—asthma	1.56e-05	5.54e-05	CcSEcCtD
Lenalidomide—PTGS2—Disease—ADCY2—asthma	1.56e-05	0.000188	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	1.56e-05	0.000188	CbGpPWpGaD
Lenalidomide—Vomiting—Triamcinolone—asthma	1.55e-05	5.49e-05	CcSEcCtD
Lenalidomide—Vomiting—Methylprednisolone—asthma	1.54e-05	5.48e-05	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—ALOX5AP—asthma	1.54e-05	0.000186	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALOX15—asthma	1.54e-05	0.000186	CbGpPWpGaD
Lenalidomide—Nausea—Hydrocortisone—asthma	1.54e-05	5.45e-05	CcSEcCtD
Lenalidomide—Rash—Triamcinolone—asthma	1.53e-05	5.45e-05	CcSEcCtD
Lenalidomide—Dermatitis—Triamcinolone—asthma	1.53e-05	5.44e-05	CcSEcCtD
Lenalidomide—Rash—Methylprednisolone—asthma	1.53e-05	5.43e-05	CcSEcCtD
Lenalidomide—Dermatitis—Methylprednisolone—asthma	1.53e-05	5.43e-05	CcSEcCtD
Lenalidomide—Urticaria—Prednisone—asthma	1.53e-05	5.42e-05	CcSEcCtD
Lenalidomide—Headache—Triamcinolone—asthma	1.52e-05	5.41e-05	CcSEcCtD
Lenalidomide—Headache—Methylprednisolone—asthma	1.52e-05	5.4e-05	CcSEcCtD
Lenalidomide—Abdominal pain—Prednisone—asthma	1.52e-05	5.4e-05	CcSEcCtD
Lenalidomide—Body temperature increased—Prednisone—asthma	1.52e-05	5.4e-05	CcSEcCtD
Lenalidomide—Diarrhoea—Dexamethasone—asthma	1.51e-05	5.36e-05	CcSEcCtD
Lenalidomide—Diarrhoea—Betamethasone—asthma	1.51e-05	5.36e-05	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—asthma	1.49e-05	0.000179	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—asthma	1.48e-05	0.000178	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CHAT—asthma	1.47e-05	0.000177	CbGpPWpGaD
Lenalidomide—Dizziness—Betamethasone—asthma	1.46e-05	5.18e-05	CcSEcCtD
Lenalidomide—Dizziness—Dexamethasone—asthma	1.46e-05	5.18e-05	CcSEcCtD
Lenalidomide—Nausea—Triamcinolone—asthma	1.45e-05	5.13e-05	CcSEcCtD
Lenalidomide—Nausea—Methylprednisolone—asthma	1.44e-05	5.12e-05	CcSEcCtD
Lenalidomide—Hypersensitivity—Prednisone—asthma	1.42e-05	5.03e-05	CcSEcCtD
Lenalidomide—Vomiting—Dexamethasone—asthma	1.4e-05	4.98e-05	CcSEcCtD
Lenalidomide—Vomiting—Betamethasone—asthma	1.4e-05	4.98e-05	CcSEcCtD
Lenalidomide—Rash—Betamethasone—asthma	1.39e-05	4.94e-05	CcSEcCtD
Lenalidomide—Rash—Dexamethasone—asthma	1.39e-05	4.94e-05	CcSEcCtD
Lenalidomide—Dermatitis—Dexamethasone—asthma	1.39e-05	4.94e-05	CcSEcCtD
Lenalidomide—Dermatitis—Betamethasone—asthma	1.39e-05	4.94e-05	CcSEcCtD
Lenalidomide—Headache—Dexamethasone—asthma	1.38e-05	4.91e-05	CcSEcCtD
Lenalidomide—Headache—Betamethasone—asthma	1.38e-05	4.91e-05	CcSEcCtD
Lenalidomide—Asthenia—Prednisone—asthma	1.38e-05	4.9e-05	CcSEcCtD
Lenalidomide—Pruritus—Prednisone—asthma	1.36e-05	4.83e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—NQO1—asthma	1.34e-05	0.000161	CbGpPWpGaD
Lenalidomide—Diarrhoea—Prednisone—asthma	1.32e-05	4.67e-05	CcSEcCtD
Lenalidomide—Nausea—Dexamethasone—asthma	1.31e-05	4.65e-05	CcSEcCtD
Lenalidomide—Nausea—Betamethasone—asthma	1.31e-05	4.65e-05	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—ALOX5—asthma	1.31e-05	0.000158	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ITPR1—asthma	1.31e-05	0.000158	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ADCY2—asthma	1.31e-05	0.000158	CbGpPWpGaD
Lenalidomide—Dizziness—Prednisone—asthma	1.27e-05	4.51e-05	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—CARM1—asthma	1.25e-05	0.000151	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CD86—asthma	1.25e-05	0.00015	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—DCN—asthma	1.23e-05	0.000148	CbGpPWpGaD
Lenalidomide—Vomiting—Prednisone—asthma	1.22e-05	4.34e-05	CcSEcCtD
Lenalidomide—Rash—Prednisone—asthma	1.21e-05	4.3e-05	CcSEcCtD
Lenalidomide—Dermatitis—Prednisone—asthma	1.21e-05	4.3e-05	CcSEcCtD
Lenalidomide—Headache—Prednisone—asthma	1.21e-05	4.28e-05	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—ALDH2—asthma	1.2e-05	0.000144	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SMAD3—asthma	1.18e-05	0.000142	CbGpPWpGaD
Lenalidomide—Nausea—Prednisone—asthma	1.14e-05	4.05e-05	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—GSTT1—asthma	1.14e-05	0.000137	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—asthma	1.13e-05	0.000136	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PPP2CA—asthma	1.13e-05	0.000136	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GSTP1—asthma	1.11e-05	0.000134	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CCR5—asthma	1.11e-05	0.000133	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HMOX1—asthma	1.1e-05	0.000132	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ITPR1—asthma	1.1e-05	0.000132	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CAT—asthma	1.08e-05	0.000131	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PDGFB—asthma	1.05e-05	0.000127	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PLA2G4A—asthma	1.02e-05	0.000123	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GSTM1—asthma	1.02e-05	0.000123	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ALB—asthma	9.99e-06	0.00012	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NQO1—asthma	9.47e-06	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPP2CA—asthma	9.43e-06	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS2—asthma	9.38e-06	0.000113	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ADCY2—asthma	9.27e-06	0.000112	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6R—asthma	8.43e-06	0.000102	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GSTP1—asthma	7.9e-06	9.52e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SERPINE1—asthma	7.9e-06	9.51e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HMOX1—asthma	7.79e-06	9.38e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ITPR1—asthma	7.77e-06	9.36e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CAT—asthma	7.69e-06	9.26e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RHOA—asthma	7.62e-06	9.17e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS3—asthma	7.54e-06	9.08e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GSTM1—asthma	7.26e-06	8.74e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLA2G4A—asthma	7.26e-06	8.74e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—POMC—asthma	7.24e-06	8.72e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CD4—asthma	6.95e-06	8.37e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPP2CA—asthma	6.69e-06	8.05e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALB—asthma	6.6e-06	7.95e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NOS3—asthma	6.31e-06	7.6e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PTEN—asthma	6.01e-06	7.24e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—STAT3—asthma	5.38e-06	6.48e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—POMC—asthma	5.13e-06	6.18e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PTEN—asthma	5.04e-06	6.06e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TGFB1—asthma	4.98e-06	6e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—EGFR—asthma	4.89e-06	5.89e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALB—asthma	4.68e-06	5.63e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NOS3—asthma	4.48e-06	5.39e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGS2—asthma	4.09e-06	4.93e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6—asthma	3.76e-06	4.52e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTEN—asthma	3.57e-06	4.3e-05	CbGpPWpGaD
